000 02346cam a2200349 a 4500
003 EG-GiCUC
005 20250223031236.0
008 150604s2014 ua dh f m 000 0 eng d
040 _aEG-GiCUC
_beng
_cEG-GiCUC
041 0 _aeng
049 _aDeposite
097 _aPh.D
099 _aCai01.11.01.Ph.D.2014.Ra.P
100 0 _aRasha Behery Youssef Zeedan
245 1 0 _aPropofol-dexmedetomidine versus propofol-ketamine for anesthesia of endoscopic retrograde cholangio-pancreatography (ERCP) /
_cRasha Behery Youssef Zeedan ; Supervised Mai Wedad Abdalla , Sahar Mohamed Moustafa Elshall , Ahmed Ibraheem Abdelkhaliq Elsombaty
246 1 5 _aالمقارنة بين بروبوفول ديكسمتيدومين و البروبوفول كيتامين فى تخدير المنظار المرتجع للقنوات المرارية و البنكرياس
260 _aCairo :
_bRasha Behery Youssef Zeedan ,
_c2014
300 _a163 Leaves :
_bcharts , facsimiles ;
_c25cm
502 _aThesis (Ph.D.) - Cairo University - Faculty of Medicine - Department of Anaesthesia
520 _aThe ideal method for anesthetic management during ERCP varied between deep sedation and general anesthesia with preference for general anesthesia over sedation. Aim of the study: To compare the effect of propofol-dexmedetomidine versus ketamine-propofol combination in patients undergoing ERCP as regard intra-procedural hemodynamic parameters (HR and MAP), total propofol consumption and recovery criteria that involved post-procedural hemodynamic parameters (HR and MAP), post-procedural pain, PONV, cognitive dysfunction Respiratory adverse events and measurement and recording of recovery time. Material and methods: Patients ERCP, age 20-50ys old, ASA II-III, were randomly allocated in two groups each of which was 30. Group-I received dexmedetomidine loading 1æg/kg slow IV over 15min then infused at a rate of 0.5æg/kg/h by syringe pump
530 _aIssued also as CD
653 4 _aERCP
653 4 _aPONV
653 4 _aTIVA
700 0 _aAhmed Ibraheem Abdelkhaliq Elsombaty ,
_eSupervisor
700 0 _aMai Wedad Abdalla ,
_eSupervisor
700 0 _aSahar Mohamed Moustafa Elshall ,
_eSupervisor
856 _uhttp://172.23.153.220/th.pdf
905 _aAml
_eCataloger
905 _aNazla
_eRevisor
942 _2ddc
_cTH
999 _c51206
_d51206